Quality control of enteral nutrition therapy in cancer patients at nutritional risk

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
AULA MEDICA EDICIONES
Citação
NUTRICION HOSPITALARIA, v.34, n.2, p.264-270, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Quality indicators in nutritional therapy (QINTs) allow for the practical assessment of quality in the management of enteral nutrition therapy (ENT) among hospitalized patients. Objective: To control ENT quality in cancer patients at nutritional risk. Methods: A prospective, observational study was performed with cancer patients over 19 years of age who had undergone exclusive ENT for at least 72 h. Nutritional Risk Screening was used to assess nutritional risk; in the presence of nutritional risk, the Subjective Global Assessment (SGA) was used. Six QINTs were applied. Results: Our study included 211 patients (mean age: 59 +/- 10 years, 67.3% men). Most common cancer diagnoses were head and neck (68.2%) and gastrointestinal (18%). Nutritional risk was identified in 93.3% (n = 197) of patients; SGA identified malnutrition in 84.2% of patients (n = 166). ENT was used for 9.7 +/- 7 days, presenting a daily deficit of-243.1 +/- 141 ml of dietary volume,-363.3 +/- 214.1 kcal, and-14.2 +/- 8.41 g of protein. Three of the six QINTs were in accordance with the proposed goal: frequency of SGA application, calculations of nutritional needs, and frequency of diarrhea. Three of the six QINTs were in disagreement with the proposed goal: ENT infused volume exceeding 70% of prescribed volume, frequency of digestive fasting exceeding 24 h, and frequency of constipation. Prescriptions for anticholinergic drugs (p = 0.023) and diuretics (p = 0.007) were associated with diarrhea. Conclusion: Nutritional risk and malnutrition are frequent among ENT cancer patients. Quality control in ENT was moderately impaired by episodes of fasting and intestinal motility disorders.
Palavras-chave
Cancer, Quality indicators, Enteral nutrition, Malnutrition, Diarrhea, Constipation
Referências
  1. Benson AB, 2004, J CLIN ONCOL, V22, P2918, DOI 10.1200/jco.2004.04.132
  2. Bittencourt AF, 2012, NUTR CLIN PRACT, V27, P533, DOI 10.1177/0884533612449488
  3. Machado RRC, 2015, NUTR HOSP, V32, P1281, DOI 10.3305/nh.2015.32.3.9266
  4. Chapple LS, 2016, CLIN NUTR, V23
  5. Chima C S, 1997, ALIMENT PHARM THER, V11, P975
  6. Ventura AMC, 2015, NUTR CLIN PRACT, V30, P351, DOI 10.1177/0884533614547765
  7. Correia MI, 2016, CLIN NUTR
  8. DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108
  9. Sanchez RE, 2015, NUTR HOSP, V32, P1408, DOI 10.3305/nh.2015.32.4.9227
  10. Faisy C, 2009, BRIT J NUTR, V101, P1079, DOI 10.1017/S0007114508055669
  11. Verotti CCG, 2015, NUTR HOSP, V31, P2692, DOI 10.3305/nh.2015.31.6.8735
  12. Verotti CCG, 2012, NUTR CLIN PRACT, V27, P261, DOI 10.1177/0884533611432317
  13. Gramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003
  14. Heyland DK, 2015, CLIN NUTR, V34, P659, DOI 10.1016/j.clnu.2014.07.008
  15. Heyland DK, 2010, JPEN-PARENTER ENTER, V34, P675, DOI 10.1177/0148607110364843
  16. Isosaki M, 2015, INDICADORES NUTR HOS
  17. Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5
  18. Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021
  19. Langius JAE, 2013, NUTR CANCER, V65, P76, DOI 10.1080/01635581.2013.741749
  20. Folguera TM, 2012, NUTR HOSP, V27, P198, DOI 10.3305/nh.2012.27.1.5557
  21. Martins JR, 2009, CLIN NUTR S S2, V4
  22. Martins JR, 2012, NUTRITION, V28, P864, DOI 10.1016/j.nut.2011.07.025
  23. McClave SA, 2016, AM J GASTROENTEROL, V111, P315, DOI 10.1038/ajg.2016.28
  24. McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234
  25. [Institut Nacional de Cancer Consenso nacional de nutricao oncologica Institute Nacional de Cancer Brasil. Ministario da Saida], 2009, CONS NAC NUTR ONC
  26. [organizacao Cristiane Aline DAlmeida Institute Nacional do Cancer Jose de Alencar Gomes da Silva Inquerito Brasileiro de Nutricao Oncologica Brasil. Ministerio da Saude], 2013, INQ BRAS NUTR ONC I
  27. Nasser APJ, 2009, J CRIT CARE, V24
  28. Oliveira Filho RS, 2014, CLIN NUTR S1, V33, P59
  29. Oliveira Filho RS, 2016, NUTR HOSP, V20, P563
  30. Oliveiro Filho RS, 2016, J INTEGR ONCOL, V5, P156
  31. Raslan M, 2011, CLIN NUTR, V30, P49, DOI 10.1016/j.clnu.2010.07.002
  32. Ribeiro Lia Mara Kauchi, 2014, Rev. bras. ter. intensiva, V26, P155, DOI 10.5935/0103-507X.20140023
  33. Shiroma GM, 2015, NUTR CLIN PRACT, V30, P406, DOI 10.1177/0884533614567540
  34. Silander E, 2013, LARYNGOSCOPE, V123, P2428, DOI 10.1002/lary.23877
  35. Waitzberg DL, 2016, JPEN-PARENTER ENTER, V40, P73, DOI 10.1177/0148607115596159
  36. Waitzberg DL, 2011, TERAPIA NUTR INDICAD
  37. Waitzberg DL, 2008, INDICADORES QUALIDAD
  38. Wang K, 2016, JPEN J PARENTER ENTE
  39. Zhang ZH, 2016, ONCOTARGETS THER, V9, P2897, DOI [10.2147/OTT.S101983, 10.2147/OTT.S10983]